AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

News & Events

Webinar: Biopharma Pre-competitive Collaboration: Delivering for Clinical Trial Excellence

November 12, 2018 | 11:00am - 12:00pm EST

Read More

7th Annual AQC Fall Member Meeting

October 30, 2018 | Princeton, NJ
Attendance at the Fall Member Meeting is one of many benefits of Membership of the Avoca Quality Consortium. Participants gain practical knowledge and experience in a casual, interactive learning environment.

Read More

ExL’s 9th Clinical Quality Oversight Forum

October 10-12, 2018 | Philadelphia, PA
Attend a presentation by Steve Whittaker, “The Impact of (R2) Sites,” and a panel discussion, “Inspection of Oversight Activities.”

Read More

Webinar: AQC Knowledge Center Monthly Demo

October 9, 2018 | 11:00am – 12:00pm EDT
Held the second Tuesday of every month and open to the industry, this Webinar offers a live demonstration of the AQC Knowledge Center. No registration is required.

Read More

Webinar: Understanding Risk-Based Monitoring Post-ICH E6 (R2)

September 25, 2018 | 11:00-12:00 EDT
Presented by Crissy MacDonald, Executive Director, Client Delivery, The Avoca Group, and Jeff Kingsley, CEO, IACT Health.

Read More

AQC Member-only Webinar

September 14, 2018 | 11:00am - 12:00pm EDT
Knowledge Center Provider Qualification Overview

Read More

Article: New ICH Guidelines Address Industry Inefficiency

By Crissy MacDonald, PhD, Executive Director, Client Delivery, The Avoca Group Applied Clinical Trials – August 23, 2018   Although the pharmaceutical industry has always incorporated risk-based processes, the ICH E6 (R2) addendum now mandates that clinical trial operations also include risk-based approaches. Based on the latest research, and The Avoca Group’s experience helping companies […]

Read More

ExL’s 7th Clinical Trials Inspection Readiness Summit

August 13-14, 2018 | Philadelphia, PA
Attend a presentation entitled, “Comparing how agencies (FDA, EMA, MHRA, Health Canada, PMDA, and CFDA) conduct inspections. What are the implications of ICH E6 (R2), based on recent inspection experiences?"

Read More

Topic Filters

All  |  None